Mid Atlantic Financial Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Mid Atlantic Financial Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.4M	Sell	18,729 -5,397	-22%	-$453K	0.09%	183
2021 Q2	$2.23M	Sell	24,126 -5,534	-19%	-$471K	0.15%	136
2021 Q1	$2.63M	Buy	29,660 +5,423	+22%	+$538K	0.19%	119
2020 Q4	$2.26M	Buy	24,237 +12,289	+103%	+$979K	0.17%	125
2020 Q3	$836K	Buy	+11,948	New	+$700K	0.07%	246

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Mid Atlantic Financial Management's ARKG Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 22% in Q3 2021, selling an estimated $453K and leaving 18,729 shares worth $1.4M. The position accounts for 0.09% of the portfolio, ranked #183.

Mid Atlantic Financial Management first reported a position in ARKG in Q3 2020 and has held it in 5 quarters since. The position peaked at $2.63M in Q1 2021. 469 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

Mid Atlantic Financial Management held 18,729 shares of ARK Genomic Revolution ETF worth $1.4M as of Q3 2021.
Mid Atlantic Financial Management sold 5,397 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $453K.
ARK Genomic Revolution ETF made up 0.09% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #183 holding.
Mid Atlantic Financial Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 5 quarters since.
Mid Atlantic Financial Management's ARK Genomic Revolution ETF position peaked at $2.63M in Q1 2021.
469 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.